Snoring - which stops suddenly for a period before resuming again.Some of the common symptoms of obstructive sleep apnea include the following: But, being aware of the signs of this condition is important to prevent further health complications. Unfortunately, a majority of people who have sleep apnea do not exhibit any clear symptoms, thus delaying the treatment. A rating between 15-30 is classified as moderate, and anything more than 30 is severe. If your AHI is less than 15, then your obstructive sleep apnea will be classified as mild. The severity is usually measured by doctors using a system known as the apnea-hypopnea index or AHI. This is the most common type of sleep apnea and can vary from being mild in some individuals to severe in others. It leads to interrupted breathing when you sleep, reducing your body’s oxygen intake and making you feel fatigued once you wake up. Obstructive sleep apnea is when the muscles in your throat relax while sleeping, thereby blocking the airways. Read on to learn more about obstructive sleep apnea and how the Night Owl Home Sleep Test can help your condition. The Night Owl Home Sleep Test is one of the most convenient methods of finding out whether you have sleep apnea. So, if you suspect that you may be suffering from this condition, the best way out is to go for a test. ![]() When left untreated, obstructive sleep apnea can lead to numerous health issues, including elevated blood pressure and heart failure. The transaction is not material to ResMed’s consolidated financial results its financial terms were not disclosed.Night Owl Home Sleep Test: Everything You Need to KnowĪre you unable to sleep well at night and have been waking up feeling tired and sleepy? Well, it may be a sign of obstructive sleep apnea - a very common sleep-related breathing disorder. It will take the combined efforts of sleep labs and connected home solutions like NightOwl to identify a significant portion of the hundreds of millions of people suffering from this disease that don’t even know it.”Įctosense will operate within ResMed’s Sleep and Respiratory Care business. We’re excited to welcome Ectosense’s life-changing team to the ResMed family.”įrederik Massie, chief technology officer and cofounder of Ectosense, says in a release, “ResMed has the global reach and passionate ambition to help increase patient access to Ectosense’s proven diagnostic solution and a path to better sleep and overall health. Ectosense’s clinically validated, consumer-friendly devices will enable us to help millions of people in many markets improve their sleep and overall health. Justin Leong, ResMed president of Asia and Latin America, says in a release, “In developing markets, we need to make sleep tests affordable, accessible and easy to use. ![]() ResMed plans to focus on scaling up in the regions where ResMed sells NightOwl today and will continually assess other opportunities. For millions of people, their best night’s sleep must start with a diagnosis.” “We believe Ectosense’s digital and easy-to-use solutions in the hands of both sleep lab technicians and consumers worldwide can help significantly increase diagnoses, as well as general awareness of this highly prevalent, 100% treatable disease. “Sleep labs and home tests each have critical roles to play in expanding our reach and identifying the 936 million people worldwide who have sleep apnea,” says Jim Hollingshead, ResMed president of Sleep & Respiratory Care, in a release. ![]() ResMed will continue to sell its ResMed ApneaLink Air home sleep test device “it’s enabled sleep labs, doctors, and other clinicians to process over 1.5 million diagnostic sleep tests in the cloud,” according to the ResMed spokesperson. A ResMed spokesperson notes in an email to Sleep Review that the NightOwl disposable HST is consumer-friendly because “it is digital and easy to use in lab or at home.” ResMed has distributed NightOwl in Australia and India since 2020 under the brand “ResMed onesleeptest,” and has been a minority investor in Ectosense since July 2020. ResMed today has completed the acquisition of Ectosense, makers of the NightOwl cloud-connected home sleep test (HST).Įctosense’s FDA-approved NightOwl is sold in the United States, Australia, New Zealand, India, and parts of Europe.
0 Comments
Leave a Reply. |